Targeted Modifications in Adeno-Associated Virus Serotype 8 Capsid Improves Its Hepatic Gene Transfer Efficiency In Vivo
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted Modifications in Adeno-Associated Virus Serotype 8 Capsid Improves Its Hepatic Gene Transfer Efficiency In Vivo
Authors
Keywords
-
Journal
Human Gene Therapy Methods
Volume 24, Issue 2, Pages 104-116
Publisher
Mary Ann Liebert Inc
Online
2013-02-27
DOI
10.1089/hgtb.2012.195
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The gene therapy journey for hemophilia: are we there yet?
- (2012) K. A. High BLOOD
- Mapping a Neutralizing Epitope onto the Capsid of Adeno-Associated Virus Serotype 8
- (2012) B. L. Gurda et al. JOURNAL OF VIROLOGY
- Proteasome Inhibition Is Partially Effective in Attenuating Pre-Existing Immunity against Recombinant Adeno-Associated Viral Vectors
- (2012) Jozsef Karman et al. PLoS One
- Universal Real-Time PCR for the Detection and Quantification of Adeno-Associated Virus Serotype 2-Derived Inverted Terminal Repeat Sequences
- (2012) Christine Aurnhammer et al. Human Gene Therapy Methods
- Single Tyrosine Mutation in AAV8 and AAV9 Capsids Is Insufficient to Enhance Gene Delivery to Skeletal Muscle and Heart
- (2012) Chunping Qiao et al. Human Gene Therapy Methods
- The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9-dependent innate immune responses in the liver
- (2011) A. T. Martino et al. BLOOD
- Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia
- (2011) C Li et al. GENE THERAPY
- AAV Vectors for Cardiac Gene Transfer: Experimental Tools and Clinical Opportunities
- (2011) Christina A Pacak et al. MOLECULAR THERAPY
- Phase 1 Gene Therapy for Duchenne Muscular Dystrophy Using a Translational Optimized AAV Vector
- (2011) Dawn E Bowles et al. MOLECULAR THERAPY
- Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
- (2011) Amit C. Nathwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activation of the NF-κB pathway by adeno-associated virus (AAV) vectors and its implications in immune response and gene therapy
- (2011) Giridhara R. Jayandharan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comparative Cardiac Gene Delivery of Adeno-Associated Virus Serotypes 1-9 reveals that AAV6 Mediates the Most Efficient Transduction in Mouse Heart
- (2010) Carmela Zincarelli et al. CTS-Clinical and Translational Science
- BALB/c Mice Show Impaired Hepatic Tolerogenic Response Following AAV Gene Transfer to the Liver
- (2010) Ekaterina Breous et al. MOLECULAR THERAPY
- Novel Properties of Tyrosine-mutant AAV2 Vectors in the Mouse Retina
- (2010) Hilda Petrs-Silva et al. MOLECULAR THERAPY
- Worldwide Epidemiology of Neutralizing Antibodies to Adeno‐Associated Viruses
- (2009) Roberto Calcedo et al. JOURNAL OF INFECTIOUS DISEASES
- Proteasome Inhibitors Decrease AAV2 Capsid derived Peptide Epitope Presentation on MHC Class I Following Transduction
- (2009) Jonathan D Finn et al. MOLECULAR THERAPY
- Innate immune responses in murine pleural mesothelial cells: Toll-like receptor-2 dependent induction of β-defensin-2 by staphylococcal peptidoglycan
- (2008) Tajamul Hussain et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Clinical gene therapy using recombinant adeno-associated virus vectors
- (2008) C Mueller et al. GENE THERAPY
- Recombinant Adeno-associated Virus Transduction and Integration
- (2008) Brian R Schultz et al. MOLECULAR THERAPY
- Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expression
- (2008) Li Zhong et al. VIROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started